Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

20091,225 citationsJournal Articlegreen Open Access

Authors

Ian M. Thompson · The University of Texas Health Science Center at San Antonio

Catherine M. Tangen · Fred Hutch Cancer Center

Jorge C. Paradelo

M. Scott Lucia · University of Colorado Health

Gary J. Miller · University of Colorado Denver

Dean A. Troyer · The University of Texas Health Science Center at San Antonio

Edward M. Messing · University of Rochester

Abstract

Adjuvant radiotherapy after radical prostatectomy for a man with pT3N0M0 prostate cancer significantly reduces the risk of metastasis and increases survival.

Topics & Keywords

Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment Hepatocellular Carcinoma Treatment and Prognosis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Journal of Urology

Volume 181, Issue 3, pp. 956-962

DOI: 10.1016/j.juro.2008.11.032

Field-Weighted Citation Impact: 78.74